CDKN2A and central nervous system cancer: According to cIMPACT-NOW update 5 and the upcoming WHO classification for tumors of the central nervous system, homozygous CDKN2A/B deletions correspond to WHO CNS grade 4 in IDH-mutant astrocytomas [23, 8].